Apogee Therapeutics, Inc.
APGE • NASDAQ • Stock Fundamentals
Apogee Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Thomas Henderson, with a market cap of $6.2B.
Market Cap$6.2B
Employees91.0
CEOMichael Thomas Henderson
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Apogee Therapeutics, Inc. FAQ
Common questions about Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. (APGE) has a market capitalization of $6.2B and trades on NASDAQ.
Apogee Therapeutics, Inc. has approximately 91 employees.